kinesin spindle protein inhibitors (Taiho/University of Shizuoka)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namekinesin spindle protein inhibitors (Taiho/University of Shizuoka)
Drug Alias NameCF-STLC
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKinesin-like protein 1 inhibitors
TargetsKinesin-like protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTaiho Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A